Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. Published
  3. 2018
  4. Published

    Is glucagon-like peptide-1 fully protected by dipeptidyl peptidase 4 inhibitor administration in patients with type 2 diabetes?

    Andersen, E. S., Lund, A., Bagger, J. I., Andreasen, C., Grøndahl, M. F., Deacon, C. F., Hartmann, B., Holst, J. J., Knop, F. K. & Vilsbøll, T., Aug 2018, In : Diabetes, Obesity and Metabolism. 20, 8, p. 1937-1943 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2017
  6. Published

    Is double-blinding achievable in a placebo-controlled trial with the glucagon-like-peptide-1 receptor agonist liraglutide?

    Foghsgaard, S., Vedtofte, L., Bahne, E., Andreasen, C., Christiansen, L. K., Svare, J., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Vilsbøll, T., 12 Sep 2017. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  7. Published
  8. Published
  9. 2008
  10. Published

    Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation

    Andreasen, C. H., Stender-Petersen, K. L., Mogensen, M. S., Torekov, S. S., Wegner, L., Andersen, G., Nielsen, A. L., Albrechtsen, A., Borch-Johnsen, K., Rasmussen, S. S., Clausen, J. O., Sandbaek, A., Lauritzen, T., Hansen, L., Jørgensen, T., Pedersen, O. & Hansen, T., Jan 2008, In : Diabetes. 57, 1, p. 95-101 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 49189675